UK Markets closed

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.0600+0.0100 (+0.49%)
As of 04:00PM EST. Market open.
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 34.7110
52-week low 31.7300
50-day moving average 32.2512
200-day moving average 32.9804

Share statistics

Avg vol (3-month) 3813.47k
Avg vol (10-day) 31.11M
Shares outstanding 5108.25M
Implied shares outstanding 6N/A
Float 858.77M
% held by insiders 10.24%
% held by institutions 184.71%
Shares short (14 Sept 2021) 47.52M
Short ratio (14 Sept 2021) 410.33
Short % of float (14 Sept 2021) 4N/A
Short % of shares outstanding (14 Sept 2021) 46.91%
Shares short (prior month 12 Aug 2021) 47.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-31.43%
Return on equity (ttm)-1,294.27%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.5M
Net income avi to common (ttm)-163.63M
Diluted EPS (ttm)-3.3670
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.47M
Total cash per share (mrq)0.22
Total debt (mrq)17.94M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.47
Book value per share (mrq)-0.22

Cash flow statement

Operating cash flow (ttm)-28.34M
Levered free cash flow (ttm)-18.8M